Join
Live feed
·
PRReleasevia Quantisnow
Pharvaris N.V. logo

Pharvaris Announces Positive Top-line Phase 2 Data from the CHAPTER-1 Study of Deucrictibant for the Prophylactic Treatment of HAE Attacks

ByQuantisnow·Wall Street's wire, on your screen.
PHVS· Pharvaris N.V.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PHVS (Pharvaris N.V.) and more on Quantisnow.